Microneedle Array‐Based Platforms for Future Theranostic Applications

Theranostics involves finding the biomarkers of a disease, fighting them through site specific drug delivery and following them for prognosis of the disease. Microneedle array technology has been used for drug delivery and extended for continuous monitoring of analytes present in the skin compartmen...

Full description

Saved in:
Bibliographic Details
Published inChembiochem : a European journal of chemical biology Vol. 20; no. 17; pp. 2198 - 2202
Main Authors Howells, Olivia, Rajendran, Natasha, Mcintyre, Sarah, Amini‐Asl, Sara, Henri, Pauline, Liu, Yufei, Guy, Owen, Cass, Anthony E. G., Morris, May C., Sharma, Sanjiv
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 02.09.2019
Wiley-VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Theranostics involves finding the biomarkers of a disease, fighting them through site specific drug delivery and following them for prognosis of the disease. Microneedle array technology has been used for drug delivery and extended for continuous monitoring of analytes present in the skin compartment. We envisage the use of microneedle arrays for future theranostic applications. The potential of combining microneedle array‐based drug delivery and diagnostics as part of closed‐loop control system for the management of diseases and delivery of precision drugs in individual patients is reported in this paper. The potential of combining microneedle array‐based drug delivery and diagnostics offers a minimally invasive route towards developing wearable closed‐loop control systems. Such systems can be used to manage a plethora of diseases that require continuous/frequent monitoring for subsequent delivery of precision drugs in individual patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1439-4227
1439-7633
DOI:10.1002/cbic.201900112